Main Title |
Development document for final effluent limitations guidelines, new source performance standards, and pretreatment standards for the pharmaceutical manufacturing point source category. |
Author |
Hund, F. H.
|
CORP Author |
Environmental Protection Agency, Washington, DC. Effluent Guidelines Div. |
Publisher |
U.S. Environmental Protection Agency, Office of Water, Effluent Guidelines Division, |
Year Published |
1983 |
Report Number |
EPA 440/1-83/084 |
Stock Number |
PB84-180066 |
OCLC Number |
16959286 |
Subjects |
Drug factories--Effluent guidelines ;
Drug factories--Environmental aspects ;
Effluent quality ;
Water--Pollution
|
Additional Subjects |
Water pollution control ;
Drug industry ;
Regulations ;
Guidelines ;
Standards ;
Sources ;
Industrial waste treatment ;
Technology ;
Cost analysis ;
Design criteria ;
Technology ;
National government ;
Pretreatment(Water) ;
Water pollution abatement ;
Point sources ;
Best technology ;
New source performance standards
|
Internet Access |
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
EJAD |
EPA 440/1-83-084 |
|
Region 3 Library/Philadelphia, PA |
09/15/1995 |
EJBD |
EPA 440-1-83-084 |
|
Headquarters Library/Washington,DC |
10/06/2015 |
ELBD ARCHIVE |
EPA 440-1-83-084 |
Received from HQ |
AWBERC Library/Cincinnati,OH |
10/04/2023 |
ESAD |
EPA 440-1-83-084 |
|
Region 10 Library/Seattle,WA |
11/08/2017 |
NTIS |
PB84-180066 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
Collation |
1 volume (various pagings) : illustrations |
Abstract |
This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of finalizing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 303, 306, 307, 308 and 501 of the Clean Water Act. The information presented supports final regulations based on best practicable control technology currently available (BPT) and best available technology (BAT), new source performance standards (NSPS) and pretreatment standards for new and existing sources (CPSNS) and (PSES) for the Pharmaceutical Manufacturing Point Source Category. The report presents and discusses data gathering efforts, consideration of subcategorization, characterization of wastewaters, selection of pollutant parameters, review of treatment technology, cost and non-water quality considerations and development of regulatory options and effluent limitations. |
Notes |
"September 1983." Includes bibliographical references. Includes glossary. |